Inspiremd announces presentation at the 2022 transcatheter cardiovascular therapeutics (tct) conference

Tel aviv, israel, sept. 13, 2022 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention system (eps) for the prevention of stroke, today announced that the company will deliver a presentation at the 2022 transcatheter cardiovascular therapeutics (tct) conference, which is being held september 16-19, 2022, at the boston convention and exhibition center in boston, ma.
NSPR Ratings Summary
NSPR Quant Ranking